Feb 12, 2019Neurotech Pharmaceuticals, Inc. Granted Fast Track Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2. View...
